Calix Valuation

Is CXL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CXL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CXL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CXL's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CXL?

Key metric: As CXL is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CXL. This is calculated by dividing CXL's market cap by their current revenue.
What is CXL's PS Ratio?
PS Ratio5.6x
SalesAU$24.19m
Market CapAU$136.65m

Price to Sales Ratio vs Peers

How does CXL's PS Ratio compare to its peers?

The above table shows the PS ratio for CXL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.4x
SDV SciDev
1x10.0%AU$106.3m
CG1 Carbonxt Group
1.8xn/aAU$26.0m
MCO Myeco Group
1xn/aAU$14.3m
RAN Range International
1.9xn/aAU$5.6m
CXL Calix
5.6x28.4%AU$136.7m

Price-To-Sales vs Peers: CXL is expensive based on its Price-To-Sales Ratio (5.6x) compared to the peer average (1.2x).


Price to Sales Ratio vs Industry

How does CXL's PS Ratio compare vs other companies in the AU Chemicals Industry?

14 CompaniesPrice / SalesEstimated GrowthMarket Cap
ORI Orica
1.1x4.1%US$5.01b
IPL Incitec Pivot
1x0.8%US$3.46b
NUF Nufarm
0.4x7.6%US$859.73m
DGL DGL Group
0.3x8.1%US$104.38m
CXL 5.6xIndustry Avg. 4.8xNo. of Companies14PS020406080100+
14 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CXL is expensive based on its Price-To-Sales Ratio (5.6x) compared to the Australian Chemicals industry average (4.8x).


Price to Sales Ratio vs Fair Ratio

What is CXL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CXL PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.6x
Fair PS Ratio3.1x

Price-To-Sales vs Fair Ratio: CXL is expensive based on its Price-To-Sales Ratio (5.6x) compared to the estimated Fair Price-To-Sales Ratio (3.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CXL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$0.75
AU$1.98
+164.4%
17.5%AU$2.40AU$1.55n/a3
Dec ’25AU$0.90
AU$1.98
+120.4%
17.5%AU$2.40AU$1.55n/a3
Nov ’25AU$0.91
AU$1.98
+119.2%
17.5%AU$2.40AU$1.55n/a3
Oct ’25AU$1.19
AU$2.43
+105.3%
18.5%AU$3.00AU$1.90n/a3
Sep ’25AU$0.95
AU$2.43
+154.8%
18.5%AU$3.00AU$1.90n/a3
Aug ’25AU$0.95
AU$3.45
+261.3%
30.4%AU$4.50AU$2.40n/a2
Jul ’25AU$1.46
AU$3.45
+136.3%
30.4%AU$4.50AU$2.40n/a2
Jun ’25AU$1.39
AU$4.80
+246.6%
6.3%AU$5.10AU$4.50n/a2
May ’25AU$1.42
AU$5.77
+306.1%
24.1%AU$7.70AU$4.50n/a3
Apr ’25AU$1.46
AU$5.77
+295.0%
24.1%AU$7.70AU$4.50n/a3
Mar ’25AU$1.78
AU$5.77
+224.9%
24.1%AU$7.70AU$4.50n/a3
Feb ’25AU$1.71
AU$6.27
+266.5%
17.2%AU$7.70AU$5.10n/a3
Jan ’25AU$3.44
AU$6.98
+103.0%
10.3%AU$7.70AU$6.00AU$0.763
Dec ’24AU$3.50
AU$6.98
+99.5%
10.3%AU$7.70AU$6.00AU$0.903
Nov ’24AU$2.84
AU$6.98
+145.9%
10.3%AU$7.70AU$6.00AU$0.913
Oct ’24AU$2.85
AU$8.27
+190.1%
22.2%AU$10.50AU$6.00AU$1.193
Sep ’24AU$3.89
AU$8.27
+112.5%
22.2%AU$10.50AU$6.00AU$0.953
Aug ’24AU$4.10
AU$8.50
+107.3%
22.0%AU$10.50AU$6.00AU$0.953
Jul ’24AU$4.18
AU$8.50
+103.3%
22.0%AU$10.50AU$6.00AU$1.463
Jun ’24AU$4.17
AU$8.50
+103.8%
22.0%AU$10.50AU$6.00AU$1.393
May ’24AU$4.74
AU$8.50
+79.3%
22.0%AU$10.50AU$6.00AU$1.423
Apr ’24AU$4.72
AU$8.50
+80.1%
22.0%AU$10.50AU$6.00AU$1.463
Mar ’24AU$5.58
AU$8.50
+52.3%
22.0%AU$10.50AU$6.00AU$1.783
Feb ’24AU$5.43
AU$8.50
+56.5%
22.0%AU$10.50AU$6.00AU$1.713
Jan ’24AU$4.50
AU$8.25
+83.5%
27.3%AU$10.50AU$6.00AU$3.442

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 15:59
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Calix Limited is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hamish MurrayBell Potter
Joseph HouseBell Potter
Conor O’PreyCanaccord Genuity